A New Alzheimer’s Treatment Option Holds Promise in Clinical Trials
If 2021 will be remembered as the year for COVID-19 vaccines, perhaps 2022 will be marked with a different version of a life-changing Alzheimer’s treatment option: a vaccine that may actually prevent or slow the further advancement of Alzheimer’s disease. The very first human trial of Protollin, delivered through nasal spray, is underway in 16 […]